BV-ICE
Phase 1/2 Completed
45 enrolled 14 charts
ImmunoSarc
Phase 1/2 Completed
197 enrolled
A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
Phase 1/2 Completed
88 enrolled 25 charts
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
Phase 1/2 Completed
117 enrolled 32 charts
BV-ICE
Phase 1/2 Completed
53 enrolled
Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma
Phase 1/2 Completed
62 enrolled 13 charts
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Phase 1/2 Completed
29 enrolled 10 charts
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
Phase 1/2 Completed
108 enrolled 7 charts
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
Phase 1/2 Completed
26 enrolled 7 charts
MRI Sarcoma Non Invasive Thermometry
Phase 1/2 Completed
15 enrolled
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Phase 1/2 Completed
55 enrolled 11 charts
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
Phase 1/2 Completed
30 enrolled
Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin
Phase 1/2 Completed
43 enrolled
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Phase 1/2 Completed
24 enrolled
Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
Phase 1/2 Completed
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
Phase 1/2 Completed
55 enrolled
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Phase 1/2 Completed
30 enrolled
Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Phase 1/2 Completed
25 enrolled
Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Phase 1/2 Completed